ConductScience.org, home

Paper6174218

Potentiation of the direct anticellular activity of mouse interferons: mutual synergism and interferon concentration dependence.

Fleischmann WR. Cancer Res, 1982. Cited by 128 papers, by iCite.

Cite this record

ConductScience Library. Potentiation of the direct anticellular activity of mouse interferons: mutual synergism and interferon concentration dependence. Papers, record 6174218. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6174218

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Potentiation of the direct anticellular activity of mouse interferons: mutual synergism and interferon concentration dependence.
PubMed
Journal
Cancer Res
PubMed
Year
1982
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
128
iCite
Relative citation ratio, by iCite
4.24
iCite
Revised in PubMed
2007-11-14
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fleischmann WR JrW R

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
InterferonsMajor topic
MelanomaMajor topic
RepliconMajor topic
Animals
Clone Cells
Mice

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
5R01 CA 26475NCI NIH HHSUnited StatesR01CA026475PubMed and NIHNIH RePORTER
5R01 CA 26476NCI NIH HHSUnited StatesR01CA026476PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 128 citations.

PMIDTitleJournalYearIn PapersSource
7923244Enhanced in vivo sensitivity to interferon with in vitro resistant B16 tumor cells in mice.Cancer Immunol Immunother1994https://conductscience.org/library/papers/7923244PubMed
6861260Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6861260PubMed
6413409Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci.Infect Immun1983https://conductscience.org/library/papers/6413409PubMed
6403469Potentiation of lymphocyte natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon.Infect Immun1983https://conductscience.org/library/papers/6403469PubMed
6319748Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons.J Virol1984https://conductscience.org/library/papers/6319748PubMed
6317573Production of gamma interferon in mice immune to Rickettsia tsutsugamushi.Infect Immun1984https://conductscience.org/library/papers/6317573PubMed
6299957Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta.Infect Immun1983https://conductscience.org/library/papers/6299957PubMed
6185431Interferon potentiation occurs at a pretranscriptive stage.Infect Immun1983https://conductscience.org/library/papers/6185431PubMed
3918301Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo.Proc Natl Acad Sci U S A1985https://conductscience.org/library/papers/3918301PubMed
3298135Alpha interferon: a look to the future.Invest New Drugs1987https://conductscience.org/library/papers/3298135PubMed
3136942Effects of scheduling and ascites-associated macrophages on combined antiproliferative activity of alpha-2b interferon and gamma-interferon in a clonogenic assay.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3136942PubMed
3114530Experimental studies on the combined effects of alpha and gamma interferons against human tumor xenografts transplanted into nude mice.Jpn J Surg1987https://conductscience.org/library/papers/3114530PubMed
3107848Interferon-gamma and cytotoxic agents studied in combination using a soft agarose human tumor clonogenic assay.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3107848PubMed
3093108A toxicity study of recombinant interferon-gamma given by intravenous infusion to patients with advanced cancer.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3093108PubMed
3018299Effect of interferon on replication of herpes simplex virus types 1 and 2 in human macrophages.J Virol1986https://conductscience.org/library/papers/3018299PubMed
2581554Regulation of cell proliferation and differentiation by interferons.Biochem J1985https://conductscience.org/library/papers/2581554PubMed
2552141Beta and gamma interferons act synergistically to produce an antiviral state in cells resistant to both interferons individually.J Virol1989https://conductscience.org/library/papers/2552141PubMed
2542574Regulation of the interferon-inducible IFI-78K gene, the human equivalent of the murine Mx gene, by interferons, double-stranded RNA, certain cytokines, and viruses.J Virol1989https://conductscience.org/library/papers/2542574PubMed
2450181Sensitivities of human glioma cell lines to interferons and double-stranded RNAs individually and in synergistic combinations.J Neurooncol1987https://conductscience.org/library/papers/2450181PubMed
2126986Antitumor effect of combination of murine recombinant interferon beta, murine recombinant interferon gamma and human recombinant interleukin-2 in MethA-bearing mice.Cancer Immunol Immunother1990https://conductscience.org/library/papers/2126986PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6174218

GET https://conductscience.org/api/papers/v1/6174218/cited_by?page=2